Literature DB >> 10467979

Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

K Honey1, S P Cobbold, H Waldmann.   

Abstract

Transplantation tolerance can be induced by a range of agents that block T cell/antigen-presenting cell (APC) interactions known to be important for initiation of the adaptive immune response. Tolerance so induced has been shown to have a regulatory phenotype dependent on CD4+ cells. This was first observed with nonlytic anti-CD4 antibodies, and was recently demonstrated following other therapeutic approaches. Dominant tolerance also plays a role in natural regulation of the immune response, functioning to prevent autoaggressive cells mediating self-destruction. The mechanism by which dominant tolerance is established and maintained remains unclear, and the reported characteristics of regulatory cells in different experimental models vary widely. Here we review the evidence for potential mechanisms involved and propose that there is a common pathway by which dominant tolerance is mediated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467979     DOI: 10.1007/BF02786503

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  95 in total

1.  Linked suppression of skin graft rejection can operate through indirect recognition.

Authors:  M P Wise; F Bemelman; S P Cobbold; H Waldmann
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

2.  Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

Authors:  S Webb; C Morris; J Sprent
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

3.  CD4+CD8- thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer.

Authors:  B Seddon; A Saoudi; M Nicholson; D Mason
Journal:  Eur J Immunol       Date:  1996-11       Impact factor: 5.532

4.  CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.

Authors:  E Suri-Payer; A Z Amar; A M Thornton; E M Shevach
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

5.  The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice.

Authors:  H K Sytwu; R S Liblau; H O McDevitt
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

6.  Administration of intragraft interleukin-4 prolongs cardiac allograft survival in rats treated with donor-specific transfusion/cyclosporine.

Authors:  A E Levy; J W Alexander
Journal:  Transplantation       Date:  1995-09-15       Impact factor: 4.939

7.  Effects of IL-12 on helper T cell-dependent immune responses in vivo.

Authors:  A J McKnight; G J Zimmer; I Fogelman; S F Wolf; A K Abbas
Journal:  J Immunol       Date:  1994-03-01       Impact factor: 5.422

8.  TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.

Authors:  B R Wong; R Josien; S Y Lee; B Sauter; H L Li; R M Steinman; Y Choi
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

9.  Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines.

Authors:  W J Karpus; K J Kennedy; S L Kunkel; N W Lukacs
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

10.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Can we learn from viruses how to prevent type 1 diabetes?: the role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapies.

Authors:  Matthias von Herrath
Journal:  Diabetes       Date:  2009-01       Impact factor: 9.461

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.